Literature DB >> 23723030

Exercise limitation following transplantation.

Trevor J Williams1, Michael J McKenna.   

Abstract

Organ transplantation is one of the medical miracles or the 20th century. It has the capacity to substantially improve exercise performance and quality of life in patients who are severely limited with chronic organ failure. We focus on the most commonly performed solid-organ transplants and describe peak exercise performance following recovery from transplantation. Across all of the common transplants, evaluated significant reduction in VO2peak is seen (typically renal and liver 65%-80% with heart and/or lung 50%-60% of predicted). Those with the lowest VO2peak pretransplant have the lowest VO2peak posttransplant. Overall very few patients have a VO2peak in the normal range. Investigation of the cause of the reduction of VO2peak has identified many factors pre- and posttransplant that may contribute. These include organ-specific factors in the otherwise well-functioning allograft (e.g., chronotropic incompetence in heart transplantation) as well as allograft dysfunction itself (e.g., chronic lung allograft dysfunction). However, looking across all transplants, a pattern emerges. A low muscle mass with qualitative change in large exercising skeletal muscle groups is seen pretransplant. Many factor posttransplant aggravate these changes or prevent them recovering, especially calcineurin antagonist drugs which are key immunosuppressing agents. This results in the reduction of VO2peak despite restoration of near normal function of the initially failing organ system. As such organ transplantation has provided an experiment of nature that has focused our attention on an important confounder of chronic organ failure-skeletal muscle dysfunction.
© 2012 American Physiological Society. Compr Physiol 2:1853-1872, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 23723030     DOI: 10.1002/cphy.c110021

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  22 in total

1.  Physical Activity and Exercise Training in Lung Transplant Recipients with Cystic Fibrosis: 'What We Know, What We Don't Know and Where to Go'.

Authors:  Thomas Radtke; Christian Benden; Susi Kriemler
Journal:  Lung       Date:  2015-12-21       Impact factor: 2.584

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

4.  Solid Organ Transplant Recipients' Opinions of Pre- and Post-Transplant Supervised Exercise Programmes: A Brief Report.

Authors:  Emma Schoo; Tanya Gustaw; Colleen Barbalinardo; Nicole Rodrigues; Yalda Zameni; Sunita Mathur; Tania Janaudis-Ferreira
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

Review 5.  Exercise after heart transplantation: An overview.

Authors:  Kari Nytrøen; Lars Gullestad
Journal:  World J Transplant       Date:  2013-12-24

6.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

Review 7.  Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.

Authors:  Daniel M Hirai; Timothy I Musch; David C Poole
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-28       Impact factor: 4.733

8.  Muscle mass predicts outcomes following liver transplantation.

Authors:  Andrea DiMartini; Ruy J Cruz; Mary Amanda Dew; Larissa Myaskovsky; Bret Goodpaster; Kristen Fox; Kevin H Kim; Paulo Fontes
Journal:  Liver Transpl       Date:  2013-11       Impact factor: 5.799

Review 9.  Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.

Authors:  Srinivasan Dasarathy
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199

10.  Treatment to improve nutrition and functional capacity evaluation in liver transplant candidates.

Authors:  Srinivasan Dasarathy
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.